Literature DB >> 1351427

Ontogenesis of pyroglutamyl peptidase II activity in rat brain, adenohypophysis and pancreas.

M A Vargas1, J Herrera, R M Uribe, J L Charli, P Joseph-Bravo.   

Abstract

Pyroglutamyl peptidase II (PPII; E.C. 3.4.19.-) is a highly specific membrane-bound ectoenzyme degrading thyrotropin releasing hormone (TRH). The ontogenesis of this enzyme was measured in rat brain regions, adenohypophysis and pancreas. In hypothalamus PPII activity was maximal at day 8 postnatal, decreasing to adult values at day 45. The postnatal ontogenic patterns in posterior cerebral cortex and hypothalamus were similar. In olfactory bulb, two peaks of activity were observed (3th and 22nd day) while in adenohypophysis it appeared only at day 8, increased to day 30, decreasing thereafter to adult values.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1351427     DOI: 10.1016/0165-3806(92)90087-d

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  6 in total

1.  The ups and downs of thyrotropin-releasing hormone.

Authors:  Kristen R Vella; Anthony N Hollenberg
Journal:  Endocrinology       Date:  2009-05       Impact factor: 4.736

2.  Regulation of adenohypophyseal pyroglutamyl aminopeptidase II activity by thyrotropin-releasing hormone and phorbol esters.

Authors:  M A Vargas; M Cisneros; P Joseph-Bravo; J L Charli
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 3.  Multifactorial modulation of TRH metabolism.

Authors:  P Joseph-Bravo; R M Uribe; M A Vargas; L Pérez-Martínez; T Zoeller; J L Charli
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

Review 4.  Advances in TRH signaling.

Authors:  Patricia Joseph-Bravo; Lorraine Jaimes-Hoy; Jean-Louis Charli
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

Review 5.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

6.  Intrauterine Zn Deficiency Favors Thyrotropin-Releasing Hormone-Increasing Effects on Thyrotropin Serum Levels and Induces Subclinical Hypothyroidism in Weaned Rats.

Authors:  Viridiana Alcántara-Alonso; Elena Alvarez-Salas; Gilberto Matamoros-Trejo; Patricia de Gortari
Journal:  Nutrients       Date:  2017-10-18       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.